We use cookies to ensure that we give you the best experience on our website Learn more

Discover early-stage research

61 - 70 of 716 documents

Therapeutic window of targeting STAT5 in CTCL

STAT5

cutaneous T cell lymphoma (CTCL)

Sézary syndrome (L-CTCL)

GJB5 association with BRAF mutation and survival in cutaneous melanoma

GJB5

BRAF

melanoma

gap junction

MAPK inhibitors

Tumor Biomarkers

Company

Legal

Follow us

© Copyright 2019 Morressier GmbH. All rights reserved.

© Copyright 2019 Morressier GmbH.
All rights reserved.